Natural Health Trends Reports Third Quarter 2017 Financial Results
Nov 01, 2017 13:02 pm UTC| Business
Positive sales momentum in emerging international marketsMaintained strong gross profit and operating income margins Announced market entry into MalaysiaIncreased quarterly dividend 9% to $0.12 per share Declared special...
Nov 01, 2017 13:02 pm UTC| Business
BERKELEY HEIGHTS, N.J., Nov. 01, 2017 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (Cyclacel or the Company), a clinical-stage biopharmaceutical company using cell cycle, transcriptional regulation and...
Determine, Inc. Shares Industry-Leading Supplier Relationship Expertise in Paystream Webinar
Nov 01, 2017 13:02 pm UTC| Business
CARMEL, Ind., Nov. 01, 2017 -- Determine, Inc. (NASDAQ:DTRM), the pioneering leader in global Source-to-Pay and Enterprise Contract Lifecycle Management (ECLM) Cloud Platform solutions, will present a live webinar with...
Stemline Announces Four SL-401 Presentations at Upcoming ASH Meeting
Nov 01, 2017 13:02 pm UTC| Business
NEW YORK, Nov. 01, 2017 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that SL-401, a novel...
Fate Therapeutics Announces Six Presentations at the 2017 ASH Annual Meeting
Nov 01, 2017 13:02 pm UTC| Business
Oral Presentation Unveiling Generation of CD8αβ+ T Cells from Engineered Pluripotent Cell Line for Off-the-Shelf CAR T-Cell Cancer Immunotherapy Oral Presentation Highlighting GMP Production of iPSC-derived NK Cell...
GoodData Takes Leadership Role in Cloud Security Compliance
Nov 01, 2017 13:01 pm UTC| Business
SAN FRANCISCO, Nov. 01, 2017 -- As May 2018 draws near and compliance with the EU’s General Data Protection Regulation (GDPR) comes closer to being required for processing personal data of European residents, companies...
Nov 01, 2017 13:01 pm UTC| Business
BOULDER, Colo., Nov. 01, 2017 -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today that new interim...
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma